TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

May 31, 2016

Conditions
Nasolabial Folds, Wrinkles
Interventions
DEVICE

TEOSYAL® RHA Ultra Deep

"A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus equi bacteria, formulated to a concentration of 23 mg/mL and 0.3% w/w lidocaine in a physiologic buffer. It is supplied in individual treatment syringes with 27Gauge ½ disposable sterile needles."

Trial Locations (4)

Unknown

United States, Beverly Hills

United States, Bradenton

United States, Chapel Hill

United States, Philadelphia

All Listed Sponsors
collaborator

ethica Clinical Research Inc.

INDUSTRY

lead

Teoxane SA

INDUSTRY

NCT02253147 - TEOSYAL® RHA Ultra Deep and Perlane-L® for the Correction of Nasolabial Folds | Biotech Hunter | Biotech Hunter